Ayan, Stephanie

Ayan, Stephanie was paid $189K by Medicaid between Feb 2018 and Apr 2024, across 5 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 36% of everything it billed.

33Billing provider infoAYAN, STEPHANIE
PORTSMOUTH, NH 03801

33aNPI1861738320assigned 01/02/2013

33bProvider typeFamily Nurse Practitioner

28Total paid$189K

24GClaims3,341

24DCodes billed5

24AFirst – last monthFeb 2018 – Apr 2024

Compared with peers

Next to other Family Nurse Practitioner providers in New Hampshire

Rank by total paid#3 of 46

Median peer was paid$4K

This provider vs. median45×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	100	$6K
2019	247	$14K
2020	453	$27K
2021	1,135	$71K
2022	1,065	$53K
2023	261	$14K
2024incomplete	80	$4K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	36%	1,551	1,117	$68K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	28%	575	454	$53K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	25%	821	619	$48K
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	9.0%	320	281	$17K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	2.2%	74	65	$4K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.